{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02911818","recordId":"NCT02911818","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02911818-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02911818.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02911818.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2016-09-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-09-20","publishedAt":"2026-08-23","recordId":"NCT02911818","recordSha256":"9cc8318c4df675baec64926b4152ab50b8b19b402b8474e02e6d1a26de3df9f7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02911818?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2017-05-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-05-24","publishedAt":"2026-08-23","recordId":"NCT02911818","recordSha256":"63b501a5818b3ab2039d86fcf309329b4bc453e9b100762d3de3e3fd259a7a3d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02911818?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Eligibility","Outcome Measures","Study Description","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2017-11-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-11-22","publishedAt":"2026-08-23","recordId":"NCT02911818","recordSha256":"53dba08557183a5da4c92896736b2a4b5d98485400263bf25a67ed5a4b88376e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02911818?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2018-08-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-08-07","publishedAt":"2026-08-23","recordId":"NCT02911818","recordSha256":"177c473784a9cbc2c0ded41cae85afbaebcdb681287128da4bc572ec90b3871e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02911818?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2018-08-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-08-07","publishedAt":"2026-08-23","recordId":"NCT02911818","recordSha256":"0bbbeba751743b55865bc8839aa1dd6fabdd7ebe33c65b94b5f24e46c879c454","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02911818?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2018-09-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-09-10","publishedAt":"2026-08-23","recordId":"NCT02911818","recordSha256":"83993ee34ecebaf502202ec6db883382835974db0f1c92c2cf27d32583a6afd5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02911818?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Arms and Interventions","Baseline Characteristics","Document Section","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2019-04-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2019-04-15","publishedAt":"2026-08-23","recordId":"NCT02911818","recordSha256":"ab7797206e381471ba36c0dc9e03ecef30529ed259026b477f441e4aec911591","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02911818?a=8&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"427d6529036e952f8c386a0ff3b40a3ec14e65537cbe896ba2e4e248a0a67a09"}}